Physician

Daniel Matthew Mcdonald, M.D,

According to 2025 Medicare claims, Daniel Mcdonald, M.D, (NPI: 1043699614) practices advanced heart failure and transplant cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is WEILL MEDICAL COLLEGE OF CORNELL (NPI: 1124333182) and primary practice location at 10065-4870. Mcdonald is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Mcdonald's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 308 traditional Medicare patients, billed 1,264 HCPCS/CPT codes, and received $117,959 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 559 prescription claims across 120 beneficiaries totaling $2,169,164 in drug costs, led by Vyndamax (Tafamidis). DME data shows 12 claims. Open Payments data shows 4 records totaling $259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $632 to $2,169,164. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	98	368	$40,654
2023	252	861	$81,350
2024	308	1,264	$117,959

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	14	$632
2016	28	117	$7,193
2017	20	240	$14,013
2018	26	324	$26,155
2019	26	193	$5,849
2020	41	252	$17,731
2021	30	179	$24,868
2022	39	111	$66,154
2023	72	314	$459,569
2024	120	559	$2,169,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$359
2024	N/R	12	$883

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	66	70	$146
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	219	$108
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	124	476	$102
36415	Insertion of needle into vein for collection of blood sample	72	112	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	47	2,220	$1,671,263
Camzyos	Mavacamten	23	675	$186,343
Entresto	Sacubitril/Valsartan	33	2,550	$54,351
Jardiance	Empagliflozin	35	2,190	$43,177
Eliquis	Apixaban	27	856	$17,724

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$883

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$259	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Matthew Mcdonald, M.D, ?

Tedicare shows public-source Medicare data for Daniel Matthew Mcdonald, M.D, (NPI 1043699614), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Matthew Mcdonald, M.D, have ACO affiliation data?

Daniel Matthew Mcdonald, M.D, is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Daniel Matthew Mcdonald, M.D, ?

Daniel Matthew Mcdonald, M.D, is linked to WEILL MEDICAL COLLEGE OF CORNELL (billing NPI 1124333182) in the available physician profile data.

Does Daniel Matthew Mcdonald, M.D, have Open Payments data?

Daniel Matthew Mcdonald, M.D, has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.